1h Free Analyst Time
The advanced drug delivery systems market is forecasted to grow by USD 225.6 billion during 2023-2028, accelerating at a CAGR of 13.3% during the forecast period. The report on the advanced drug delivery systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising chronic disease, rising investment in research and development of drug delivery, and rising healthcare expenditure globally.
The advanced drug delivery systems market is segmented as below:
By Type
- Oral
- Injection and inhalation
- Transdermal
- Carrier-based
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the advanced drug delivery systems market covers the following areas:
- Advanced Drug Delivery Systems Market sizing
- Advanced Drug Delivery Systems Market forecast
- Advanced Drug Delivery Systems Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Customer Landscape
10 Geographic Landscape
11 Drivers, Challenges, and Opportunity/Restraints
12 Competitive Landscape
13 Competitive Analysis
14 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global advanced drug delivery systems market: 3M Co., Alfresa Holdings Corp., Alkermes Public Ltd. Co., AmerisourceBergen Corp., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Co., Cardinal Health Inc., Endo International Plc, J M Smith Corp., NanoPass Technologies Ltd., Nektar Therapeutics, Perrigo Co. Plc, Philip Morris International Inc., Prodigy Health, Surmodics Inc., Teva Pharmaceutical Industries Ltd., UCB SA, and Ypsomed Holding AG.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in nanotechnology."
According to the report, one of the major drivers for this market is the rising chronic disease.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Co.
- Alfresa Holdings Corp.
- Alkermes Public Ltd. Co.
- AmerisourceBergen Corp.
- Antares Pharma Inc.
- Baxter International Inc.
- Bayer AG
- Becton Dickinson and Co.
- Cardinal Health Inc.
- Endo International Plc
- J M Smith Corp.
- NanoPass Technologies Ltd.
- Nektar Therapeutics
- Perrigo Co. Plc
- Philip Morris International Inc.
- Prodigy Health
- Surmodics Inc.
- Teva Pharmaceutical Industries Ltd.
- UCB SA
- Ypsomed Holding AG
